EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis

Cellular Microbiology

Volumn 10, Issue 5, 2008, Pages 1104-1115

  Marchès, Oliver ^a   Covarelli, Valentina ^a   Dahan, Sivan ^a   Cougoule, Céline ^a   Bhatta, Pallavi ^a   Frankel, Gad ^a   Caron, Emmanuelle ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI SECRETED PROTEIN F; ESCHERICHIA COLI SECRETED PROTEIN J; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE EXPRESSION; GENETIC COMPLEMENTATION; IN VITRO STUDY; INTERNALIZATION; MACROPHAGE; NONHUMAN; OPSONIZATION; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; TYPE III SECRETION SYSTEM;

ANIMALS; CARRIER PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; MACROPHAGE-1 ANTIGEN; MACROPHAGES; OPSONIN PROTEINS; PHAGOCYTOSIS; TRANSFECTION;

ESCHERICHIA COLI; MAMMALIA; OVIS ARIES;

EID: 42149144665     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.01112.x     Document Type: Article

References (59)

1. Allen, L.A., and Aderem, A. (1996) Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med 184: 627-637.
2. Braun, V., and Niedergang, F. (2006) Linking exocytosis and endocytosis during phagocytosis. Biol Cell 98: 195-201.
3. Braun, V., Fraisier, V., Raposo, G., Hurbain, I., Sibarita, J.B., Chavrier, P., et al. (2004) TI-VAMP/VAMP7 is required for optimal phagocytosis of opsonised particles in macrophages. EMBO J 23: 4166-4176.
4. Caron, E., and Hall, A. (1998) Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282: 1717-1721.
5. Caron, E., Self, A.J., and Hall, A. (2000) The GTPase Rap1 controls functional activation of macrophage integrin alpha M beta 2 by LPS and other inflammatory mediators. Curr Biol 10: 974-978.
6. Caron, E., Crepin, V.F., Simpson, N., Knutton, S., Garmendia, J., and Frankel, G. (2006) Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9: 40-45.
7. Celli, J., Olivier, M., and Finlay, B.B. (2001) Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J 20: 1245-1258.
8. Chaves-Olarte, E., Low, P., Freer, E., Norlin, T., Weidmann, M., von Eichel-Streiber, C., and Thelestam, M. (1999) A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem 274: 11046-11052.
9. Collington, G.K., Booth, I.W., Donnenberg, M.S., Kaper, J.B., and Knutton, S. (1998) Enteropathogenic Escherichia coli virulence genes encoding secreted signalling proteins are essential for modulation of Caco-2 cell electrolyte transport. Infect Immun 66: 6049-6053.
10. Coombes, B.K., Valdez, Y., and Finlay, B.B. (2004) Evasive manoeuvres by secreted bacterial proteins to avoid innate immune responses. Curr Biol 14: R856-R867.
11. Cougoule, C., Hoshino, S., Dart, A., Lim, J., and Caron, E. (2006) Dissociation of recruitment and activation of the small G-protein Rac during Fcgamma receptor-mediated phagocytosis. J Biol Chem 281: 8756-8764.
12. Crane, J.K., McNamara, B.P., and Donnenberg, M.S. (2001) Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol 3: 197-211.
13. Dahan, S., Wiles, S., La Ragione, R.M., Best, A., Woodward, M.J., Stevens, M.P., et al. (2005) EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun 73: 679-686.
14. Datsenko, K.A., and Wanner, B.L. (2000) One-step inactivation of chromosomal in Escherichia coli K12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
15. Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P.H., Steele-Mortimer, O., et al. (2002) Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110: 119-131.
16. Garmendia, J., Phillips, A.D., Carlier, M.F., Chong, Y., Schuller, S., Marchès, O., et al. (2004) TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol 6: 1167-1183.
17. Garmendia, J., Frankel, G., and Crepin, V.F. (2005) Enteropathogenic and enterohaemorrhagic E.coli infections: Translocation, translocation, translocation. Infect Immun 73: 2586-2594.
18. Giammanco, G.M., Pignato, S., Mammina, C., Grimont, F., Grimont, P.A., Nastasi, A., et al. (2002) Persistent endemicity of Salmonella bongori 48:z(35):-Mouthern Italy: molecular characterization of human, animal, and environmental isolates. J Clin Microbiol 40: 3502-3505.
19. Goosney, D.L., Celli, J., Kenny, B., and Finlay, B.B. (1999) Enteropathogenic Escherichia coli inhibits phagocytosis. Infect Immun 67: 490-495.
20. Gruenheid, S., Sekirov, I., Thomas, N.A., Deng, W., O'Donnell, P., Goode, D., et al. (2004) Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51: 1233-1249.
21. Hardwidge, P.R., Deng, W., Vallance, B.A., Rodriguez-Escudero, I., Cid, V.J., Molina, M.F., et al. (2005) Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG. Infect Immun 73: 2586-2594.
22. Inman, L.R., and Cantey, J.R. (1983) Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit. J Clin Invest 71: 1-8.
23. Jaffe, A.B., and Hall, A. (2005) Rho GTPases: Biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269.
24. Jarvis, K.G., Giron, J.A., Jerse, A.E., McDaniel, T.K., Donnenberg, M.S., and Kaper, J.B. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci USA 92: 7996-8000.
25. Jerse, A.E., Yu, J., Tall, B.D., and Kaper, J.B. (1990) A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87: 7839-7843.
26. Just, I., Selzer, J., Wilm, M., von Eichel-Streiber, C., Mann, M., and Aktories, K. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503.
27. Kanack, K.J., Crawford, J.A., Tatsuno, I., Karmali, M.A., and Kaper, J.B. (2005) SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun 73: 4327-4337.
28. Kaper, J.B., Nataro, J.P., and Mobley, H.L. (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140.
29. Kenny, B., DeVinney, R., Stein, M., Reinscheid, D.J., Frey, E.A., and Finlay, B.B. (1997) Enteropathogenic E.coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-520.
30. Kenny, B., Ellis, S., Leard, A.D., Warawa, J., Mellor, H., and Jepson, M.A. (2002) Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol 44: 1095-1107.
31. Knutton, S., Lloyd, D.R., and McNeish, A.S. (1987) Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun 55: 69-77.
32. Levine, M.M., Berquist, E.J., Nalin, D.R., Waterman, D.H., Hornick, R.B., Young, C.R., et al. (1978) Escherichia coli that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 27: 1119-1122.
33. McDaniel, T.K., Jarvis, K.G., Donnenberg, M.S., and Kaper, J.B. (1995) A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci USA 92: 1664-1668.
34. McNamara, B.P., Koutsouris, A., O'Connell, C.B., Nougayrède, J.P., Donnenberg, M.S., and Hecht, G. (2001) Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107: 621-629.
35. Marchès, O., Wiles, S., Dziva, F., La Ragione, R.M., Schuller, S., Best, A., et al. (2005) Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun 73: 8411-8417.
36. Marchès, O., Batchelor, M., Shaw, R.K., Patel, A., Cummings, N., Nagai, T., et al. (2006) EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J Bacteriol 188: 3110-3115.
37. Martinez-Argudo, I., Sands, C., and Jepson, M.A. (2007) Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. Cell Microbiol 9: 1538-1546.
38. Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C., and Abe, A. (2004) Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J 23: 3570-3582.
39. Mundy, R., Petrovska, L., Smollett, K., Simpson, N., Wilson, R.K., Yu, J., et al. (2004) Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun 72: 2288-3302.
40. Nagai, T., Abe, A., and Sasakawa, C. (2005) Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: Critical role of the 16th leucine residue in EspF. J Biol Chem 280: 2998-3011.
41. Niedergang, F., and Chavrier, P. (2005) Regulation of phagocytosis by Rho GTPases. Curr Top Microbiol Immunol 291: 43-60.
42. Nougayrède, J.P., and Donnenberg, M.S. (2004) Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol 6: 1097-1111.
43. Ochman, H., and Groisman, E.A. (1996) Distribution of pathogenicity islands in Salmonella spp. Infect Immun 64: 5410-5412.
44. Patel, J.C., Hall, A., and Caron, E. (2002) Vav regulates activation of Rac but not Cdc42 during FcgammaR-mediated phagocytosis. Mol Biol Cell 13: 1215-1226.
45. Phillips, A.D., Navabpour, S., Hicks, S., Dougan, G., Wallis, T., and Frankel, G. (2000) Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 47: 377-381.
46. Quitard, S., Dean, P., Maresca, M., and Kenny, B. (2006) The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell Microbiol 8: 972-981.
47. Reid, S.D., Herbelin, C.J., Bumbaugh, A.C., Selander, R.K., and Whittam, T.S. (2000) Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406: 64-67.
48. Rottner, K., Stradal, T.E., and Wehland, J. (2005) Bacteria-host-cell interactions at the plasma membrane: Stories on actin cytoskeleton subversion. Dev Cell 9: 3-17.
49. Schlosser-Silverman, E., Elgrably-Weiss, M., Rosenshine, I., Kohen, R., and Altuvia, S. (2000) Characterization of Escherichia coli DNA lesions generated within J774 macrophages. J Bacteriol 182: 5225-5230.
50. Shaw, R.K., Cleary, J., Frankel, G., and Knutton, S. (2005a) Enteropathogenic Escherichia coli interaction with human intestinal mucosa: Role of effector proteins in brush border remodelling and 'attaching & effacing' lesion formation. Infect Immun 73: 1243-1251.
51. Shaw, R.K., Smollett, K., Cleary, J., Garmendia, J., Straatman-Iwanowska, A., Frankel, G., et al. (2005b) Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells. Infect Immun 73: 4385-4390.
52. Simpson, N., Shaw, R., Crepin, V.F., Mundy, R., Fitzgerald, A.J., Cummings, N., et al. (2006) The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: Implication for cell signalling and diarrhoea. Mol Microbiol 60: 349-363.
53. Spears, K.J., Roe, A.J., and Gally, D.L. (2006) A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett 255: 187-202.
54. Stevens, M.P., Roe, A.J., Vlisidou, I., Van Diemen, P.M., La Ragione, R.M., Best, A., et al. (2004) Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep. Infect Immun 72: 5402-5411.
55. Tobe, T., Beatson, S.A., Taniguchi, H., Abe, H., Bailey, C.M., Fivian, A., et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 103: 14941-14946.
56. Tomson, F.L., Viswanathan, V.K., Kanack, K.J., Kanteti, R.P., Straub, K.V., Menet, M., et al. (2005) Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol 56: 447-464.
57. Valdivia, R.H., and Falkow, S. (1996) Bacterial genetics by flow cytometry: Rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction. Mol Microbiol 22: 367-378.
58. Waterman, S.R., and Holden, D.W. (2003) Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 5: 501-511.
59. Wiles, S., Clare, S., Harker, J., Huett, A., Young, D., Dougan, G., and Frankel, G. (2004) Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6: 963-972.